메뉴 건너뛰기




Volumn 2017, Issue , 2017, Pages

P-glycoprotein (ABCB1) and oxidative stress: Focus on Alzheimer⇔s disease

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY;

EID: 85041863214     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/7905486     Document Type: Review
Times cited : (53)

References (148)
  • 1
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics
    • J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2012.
    • (2012) Science , vol.297 , Issue.5580 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 2
    • 85030620541 scopus 로고    scopus 로고
    • Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer’s and mild cognitive impairment patients
    • N. Arce-Varas, G. Abate, C. Prandelli et al., “Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer’s and mild cognitive impairment patients,” Current Alzheimer Research, vol. 14, no. 1, pp. 112–122, 2017.
    • (2017) Current Alzheimer Research , vol.14 , Issue.1 , pp. 112-122
    • Arce-Varas, N.1    Abate, G.2    Prandelli, C.3
  • 4
    • 84881525560 scopus 로고    scopus 로고
    • Oxidative stress and the pathogenesis of Alzheimer’s disease
    • Y. Zhao and B. Zhao, “Oxidative stress and the pathogenesis of Alzheimer’s disease,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 316523, 10 pages, 2013.
    • (2013) Oxidative Medicine and Cellular Longevity , vol.2013 , pp. 10
    • Zhao, Y.1    Zhao, B.2
  • 5
    • 78650678688 scopus 로고    scopus 로고
    • Decreased clearance of CNS β-amyloid in Alzheimer’s disease
    • K. G. Mawuenyega, W. Sigurdson, and V. Ovod, “Decreased clearance of CNS β-amyloid in Alzheimer’s disease,” Science, vol. 330, no. 6012, p. 1774, 2010.
    • (2010) Science , vol.330 , Issue.6012 , pp. 1774
    • Mawuenyega, K.G.1    Sigurdson, W.2    Ovod, V.3
  • 6
    • 0036462453 scopus 로고    scopus 로고
    • Alzheimer’s disease and the amyloid cascade hypothesis: Ten years on
    • B. Sommer, “Alzheimer’s disease and the amyloid cascade hypothesis: ten years on,” Current Opinion in Pharmacology, vol. 2, no. 1, pp. 87–92, 2002.
    • (2002) Current Opinion in Pharmacology , vol.2 , Issue.1 , pp. 87-92
    • Sommer, B.1
  • 8
    • 67349158815 scopus 로고    scopus 로고
    • Variations in the neuropathology of familial Alzheimer’s disease
    • C. Shepherd, H. McCann, and G. M. Halliday, “Variations in the neuropathology of familial Alzheimer’s disease,” Acta Neuropathologica, vol. 118, no. 1, pp. 37–52, 2009.
    • (2009) Acta Neuropathologica , vol.118 , Issue.1 , pp. 37-52
    • Shepherd, C.1    McCann, H.2    Halliday, G.M.3
  • 9
    • 3042576053 scopus 로고    scopus 로고
    • The amyloid hypothesis and the clearance and degradation of Alzheimer’s β-peptide
    • H. LeVine, “The amyloid hypothesis and the clearance and degradation of Alzheimer’s β-peptide,” Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 303–314, 2004.
    • (2004) Journal of Alzheimer'S Disease , vol.6 , Issue.3 , pp. 303-314
    • LeVine, H.1
  • 10
    • 65649105035 scopus 로고    scopus 로고
    • Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease
    • R. Deane, R. D. Bell, A. Sagare, and B. V. Zlokovic, “Clearance of amyloid-β peptide across the blood-brain barrier: implication for therapies in Alzheimer’s disease,” CNS & Neurological Disorders - Drug Targets, vol. 8, no. 1, pp. 16–30, 2009.
    • (2009) CNS & Neurological Disorders - Drug Targets , vol.8 , Issue.1 , pp. 16-30
    • Deane, R.1    Bell, R.D.2    Sagare, A.3    Zlokovic, B.V.4
  • 11
    • 84863393540 scopus 로고    scopus 로고
    • Blood-brain barrier P-glycoprotein function in Alzheimer’s disease
    • D. M. E. van Assema, M. Lubberink, M. Bauer et al., “Blood-brain barrier P-glycoprotein function in Alzheimer’s disease,” Brain, vol. 135, Part 1, pp. 181–189, 2012.
    • (2012) Brain , vol.135 , pp. 181-189
    • Van Assema, D.M.E.1    Lubberink, M.2    Bauer, M.3
  • 12
    • 1842610700 scopus 로고    scopus 로고
    • The ABC transporter structure and mechanism: Perspectives on recent research
    • P. M. Jones and A. M. George, “The ABC transporter structure and mechanism: perspectives on recent research,” Cellular and Molecular Life Sciences, vol. 61, no. 6, pp. 682–699, 2004.
    • (2004) Cellular and Molecular Life Sciences , vol.61 , Issue.6 , pp. 682-699
    • Jones, P.M.1    George, A.M.2
  • 13
    • 80053556127 scopus 로고    scopus 로고
    • The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier
    • S. Vogelgesang, G. Jedlitschky, A. Brenn, and L. C. Walker, “The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier,” Current Pharmaceutical Design, vol. 17, no. 26, pp. 2778–2786, 2011.
    • (2011) Current Pharmaceutical Design , vol.17 , Issue.26 , pp. 2778-2786
    • Vogelgesang, S.1    Jedlitschky, G.2    Brenn, A.3    Walker, L.C.4
  • 14
    • 27644489474 scopus 로고    scopus 로고
    • P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
    • J. R. Cirrito, R. Deane, A. M. Fagan et al., “P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model,” The Journal of Clinical Investigation, vol. 115, no. 11, pp. 3285–3290, 2005.
    • (2005) The Journal of Clinical Investigation , vol.115 , Issue.11 , pp. 3285-3290
    • Cirrito, J.R.1    Deane, R.2    Fagan, A.M.3
  • 15
    • 0030854715 scopus 로고    scopus 로고
    • Cellular energy utilization and molecular origin of standard metabolic rate in mammals
    • D. F. Rolfe and G. C. Brown, “Cellular energy utilization and molecular origin of standard metabolic rate in mammals,” Physiological Reviews, vol. 77, no. 3, pp. 731–758, 1997.
    • (1997) Physiological Reviews , vol.77 , Issue.3 , pp. 731-758
    • Rolfe, D.F.1    Brown, G.C.2
  • 16
    • 6944255523 scopus 로고    scopus 로고
    • Delivery of therapeutic agents to the central nervous system: The problems and the possibilities
    • D. J. Begley, “Delivery of therapeutic agents to the central nervous system: the problems and the possibilities,” Pharmacology & Therapeutics, vol. 104, no. 1, pp. 29–45, 2004.
    • (2004) Pharmacology & Therapeutics , vol.104 , Issue.1 , pp. 29-45
    • Begley, D.J.1
  • 17
    • 84866665561 scopus 로고    scopus 로고
    • Blood-brain barrier integrity and glial support: Mechanisms that can be targeted for novel therapeutic approaches in stroke
    • P. T. Ronaldson and T. P. Davis, “Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke,” Current Pharmaceutical Design, vol. 18, no. 25, pp. 3624–3644, 2012.
    • (2012) Current Pharmaceutical Design , vol.18 , Issue.25 , pp. 3624-3644
    • Ronaldson, P.T.1    Davis, T.P.2
  • 18
    • 84878231468 scopus 로고    scopus 로고
    • Targeted drug delivery to treat pain and cerebral hypoxia
    • P. T. Ronaldson and T. P. Davis, “Targeted drug delivery to treat pain and cerebral hypoxia,” Pharmacological Reviews, vol. 65, no. 1, pp. 291–314, 2013.
    • (2013) Pharmacological Reviews , vol.65 , Issue.1 , pp. 291-314
    • Ronaldson, P.T.1    Davis, T.P.2
  • 19
    • 0033377523 scopus 로고    scopus 로고
    • Physiology and pathology of the blood-brain barrier: Implications for microbial pathogenesis, drug delivery and neurodegenerative disorders
    • W. A. Banks, “Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders,” Journal of Neurovirol-ogy, vol. 5, no. 6, pp. 538–555, 1999.
    • (1999) Journal of Neurovirol-Ogy , vol.5 , Issue.6 , pp. 538-555
    • Banks, W.A.1
  • 20
    • 0036206904 scopus 로고    scopus 로고
    • The impact of efflux transporters in the brain on the development of drugs for CNS disorders
    • E. M. Taylor, “The impact of efflux transporters in the brain on the development of drugs for CNS disorders,” Clinical Pharmacokinetics, vol. 41, no. 2, pp. 81–92, 2002.
    • (2002) Clinical Pharmacokinetics , vol.41 , Issue.2 , pp. 81-92
    • Taylor, E.M.1
  • 21
    • 0030099527 scopus 로고    scopus 로고
    • Transporting therapeutics across the blood-brain barrier
    • N. J. Abbott and I. A. Romero, “Transporting therapeutics across the blood-brain barrier,” Molecular Medicine Today, vol. 2, no. 3, pp. 106–113, 1996.
    • (1996) Molecular Medicine Today , vol.2 , Issue.3 , pp. 106-113
    • Abbott, N.J.1    Romero, I.A.2
  • 22
    • 48949117579 scopus 로고    scopus 로고
    • Lysosomal storage diseases and the blood-brain barrier
    • D. J. Begley, C. C. Pontikis, and M. Scarpa, “Lysosomal storage diseases and the blood-brain barrier,” Current Pharmaceutical Design, vol. 14, no. 16, pp. 1566–1580, 2008.
    • (2008) Current Pharmaceutical Design , vol.14 , Issue.16 , pp. 1566-1580
    • Begley, D.J.1    Pontikis, C.C.2    Scarpa, M.3
  • 24
    • 19544376509 scopus 로고    scopus 로고
    • Free radicals as triggers of brain edema formation after stroke
    • J. H. Heo, S. W. Han, and S. K. Lee, “Free radicals as triggers of brain edema formation after stroke,” Free Radical Biology and Medicine, vol. 39, no. 1, pp. 51–70, 2005.
    • (2005) Free Radical Biology and Medicine , vol.39 , Issue.1 , pp. 51-70
    • Heo, J.H.1    Han, S.W.2    Lee, S.K.3
  • 25
    • 84941316599 scopus 로고    scopus 로고
    • Targeting transporters: Promoting blood-brain barrier repair in response to oxidative stress injury
    • P. T. Ronaldson and T. P. Davis, “Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury,” Brain Research, vol. 1623, pp. 39–52, 2015.
    • (2015) Brain Research , vol.1623 , pp. 39-52
    • Ronaldson, P.T.1    Davis, T.P.2
  • 27
    • 2442696471 scopus 로고    scopus 로고
    • Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia
    • S. Dallas, L. Schlichter, and R. Bendayan, “Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia,” Journal of Pharmacology and Experimental Therapeutics, vol. 309, no. 3, pp. 1221–1229, 2004.
    • (2004) Journal of Pharmacology and Experimental Therapeutics , vol.309 , Issue.3 , pp. 1221-1229
    • Dallas, S.1    Schlichter, L.2    Bendayan, R.3
  • 30
    • 84856414098 scopus 로고    scopus 로고
    • Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain
    • J. J. Lochhead, G. McCaffrey, L. Sanchez-Covarrubias et al., “Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 302, no. 3, pp. H582–H593, 2012.
    • (2012) American Journal of Physiology - Heart and Circulatory Physiology , vol.302 , Issue.3 , pp. H582-H593
    • Lochhead, J.J.1    McCaffrey, G.2    Sanchez-Covarrubias, L.3
  • 31
    • 33846863589 scopus 로고    scopus 로고
    • Nitric oxide and peroxynitrite in health and disease
    • P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007.
    • (2007) Physiological Reviews , vol.87 , Issue.1 , pp. 315-424
    • Pacher, P.1    Beckman, J.S.2    Liaudet, L.3
  • 32
  • 33
    • 35948971753 scopus 로고    scopus 로고
    • Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling
    • G. Schreibelt, G. Kooij, and A. Reijerkerk, “Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling,” The FASEB Journal, vol. 21, no. 13, pp. 3666–3676, 2007.
    • (2007) The FASEB Journal , vol.21 , Issue.13 , pp. 3666-3676
    • Schreibelt, G.1    Kooij, G.2    Reijerkerk, A.3
  • 34
    • 77956247309 scopus 로고    scopus 로고
    • Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation
    • J. J. Lochhead, G. McCaffrey, C. E. Quigley et al., “Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation,” Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 9, pp. 1625–1636, 2010.
    • (2010) Journal of Cerebral Blood Flow & Metabolism , vol.30 , Issue.9 , pp. 1625-1636
    • Lochhead, J.J.1    McCaffrey, G.2    Quigley, C.E.3
  • 35
    • 84880331059 scopus 로고    scopus 로고
    • Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery
    • Y. Yang, J. F. Thompson, S. Taheri et al., “Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery,” Journal of Cerebral Blood Flow & Metabolism, vol. 33, no. 7, pp. 1104–1114, 2013.
    • (2013) Journal of Cerebral Blood Flow & Metabolism , vol.33 , Issue.7 , pp. 1104-1114
    • Yang, Y.1    Thompson, J.F.2    Taheri, S.3
  • 36
    • 84903751395 scopus 로고    scopus 로고
    • Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: Consequences for interendothe-lial adherens and tight junctions
    • K. D. Rochfort, L. E. Collins, R. P. Murphy, and P. M. Cummins, “Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothe-lial adherens and tight junctions,” PLoS One, vol. 9, no. 7, article e101815, 2014.
    • (2014) PLoS One , vol.9 , Issue.7 , pp. e101815
    • Rochfort, K.D.1    Collins, L.E.2    Murphy, R.P.3    Cummins, P.M.4
  • 37
    • 84879495507 scopus 로고    scopus 로고
    • The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer’s disease
    • A. Elali and S. Rivest, “The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer’s disease,” Frontiers in Physiolology, vol. 4, p. 45, 2013.
    • (2013) Frontiers in Physiolology , vol.4 , pp. 45
    • Elali, A.1    Rivest, S.2
  • 38
    • 0346887115 scopus 로고    scopus 로고
    • Structure and function of efflux pumps that confer resistance to drugs
    • M. I. Borges-Walmsley, K. S. McKeegan, and A. R. Walmsley, “Structure and function of efflux pumps that confer resistance to drugs,” Biochemical Journal, vol. 376, no. 2, pp. 313–338, 2003.
    • (2003) Biochemical Journal , vol.376 , Issue.2 , pp. 313-338
    • Borges-Walmsley, M.I.1    McKeegan, K.S.2    Walmsley, A.R.3
  • 39
    • 34247123807 scopus 로고    scopus 로고
    • Structure and function of ABC transporters
    • K. J. Linton, “Structure and function of ABC transporters,” Physiology, vol. 22, no. 2, pp. 122–130, 2007.
    • (2007) Physiology , vol.22 , Issue.2 , pp. 122-130
    • Linton, K.J.1
  • 40
    • 0037457802 scopus 로고    scopus 로고
    • Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview
    • A. H. Schinkel and J. W. Jonker, “Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview,” Advanced Drug Delivery Reviews, vol. 55, no. 1, pp. 3–29, 2003.
    • (2003) Advanced Drug Delivery Reviews , vol.55 , Issue.1 , pp. 3-29
    • Schinkel, A.H.1    Jonker, J.W.2
  • 42
    • 12344262373 scopus 로고    scopus 로고
    • Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
    • W. Löscher and H. Potschka, “Blood-brain barrier active efflux transporters: ATP-binding cassette gene family,” Neu-roRx, vol. 2, no. 1, pp. 86–98, 2005.
    • (2005) Neu-roRx , vol.2 , Issue.1 , pp. 86-98
    • Löscher, W.1    Potschka, H.2
  • 43
    • 33846703691 scopus 로고    scopus 로고
    • Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
    • E. Bakos and L. Homolya, “Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1),” Pflügers Archiv-European Journal of Physiology, vol. 453, no. 5, pp. 621–641, 2007.
    • (2007) Pflügers Archiv-European Journal of Physiology , vol.453 , Issue.5 , pp. 621-641
    • Bakos, E.1    Homolya, L.2
  • 44
    • 4644292545 scopus 로고    scopus 로고
    • Potential role of ABC transporters as a detoxification system at the blood–CSF barrier
    • E. C. M. de Lange, “Potential role of ABC transporters as a detoxification system at the blood–CSF barrier,” Advanced Drug Delivery Reviews, vol. 56, no. 12, pp. 1793–1809, 2004.
    • (2004) Advanced Drug Delivery Reviews , vol.56 , Issue.12 , pp. 1793-1809
    • De Lange, E.C.M.1
  • 45
    • 17544368685 scopus 로고    scopus 로고
    • Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
    • E. M. Leslie, R. G. Deeley, and S. P. C. Cole, “Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense,” Toxicology and Applied Pharmacology, vol. 204, no. 3, pp. 216–237, 2005.
    • (2005) Toxicology and Applied Pharmacology , vol.204 , Issue.3 , pp. 216-237
    • Leslie, E.M.1    Deeley, R.G.2    Cole, S.P.C.3
  • 46
    • 77953687856 scopus 로고    scopus 로고
    • Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
    • D. S. Miller, “Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier,” Trends in Pharmacolological Sciences, vol. 31, no. 6, pp. 246–254, 2010.
    • (2010) Trends in Pharmacolological Sciences , vol.31 , Issue.6 , pp. 246-254
    • Miller, D.S.1
  • 47
    • 80053504148 scopus 로고    scopus 로고
    • Blood-brain barrier P-glycoprotein function in neurodegenerative disease
    • A. L. Bartels, “Blood-brain barrier P-glycoprotein function in neurodegenerative disease,” Current Pharmaceutical Design, vol. 17, no. 26, pp. 2771–2777, 2011.
    • (2011) Current Pharmaceutical Design , vol.17 , Issue.26 , pp. 2771-2777
    • Bartels, A.L.1
  • 49
  • 50
    • 0027363563 scopus 로고
    • Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospho-lipid from bile and to liver disease
    • J. J. M. Smit, A. H. Schinkel, R. P. J. Oude Elferink et al., “Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospho-lipid from bile and to liver disease,” Cell, vol. 75, no. 3, pp. 451–462, 1993.
    • (1993) Cell , vol.75 , Issue.3 , pp. 451-462
    • Smit, J.J.M.1    Schinkel, A.H.2    Oude Elferink, R.P.J.3
  • 51
    • 0036605677 scopus 로고    scopus 로고
    • Functional expression and localization of P-glycoprotein at the blood brain barrier
    • R. Bendayan, G. Lee, and M. Bendayan, “Functional expression and localization of P-glycoprotein at the blood brain barrier,” Microscopy Research & Technique, vol. 57, no. 5, pp. 365–380, 2002.
    • (2002) Microscopy Research & Technique , vol.57 , Issue.5 , pp. 365-380
    • Bendayan, R.1    Lee, G.2    Bendayan, M.3
  • 52
    • 53149117869 scopus 로고    scopus 로고
    • Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces
    • S. Gazzin, N. Strazielle, C. Schmitt et al., “Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces,” The Journal of Comparative Neurology, vol. 510, no. 5, pp. 497–507, 2008.
    • (2008) The Journal of Comparative Neurology , vol.510 , Issue.5 , pp. 497-507
    • Gazzin, S.1    Strazielle, N.2    Schmitt, C.3
  • 54
    • 84875239504 scopus 로고    scopus 로고
    • ABC transporters and the Alzheimer’s disease enigma
    • A. Wolf, B. Bauer, and A. M. S. Hartz, “ABC transporters and the Alzheimer’s disease enigma,” Frontiers in Psychiatry, vol. 3, pp. 1–14, 2012.
    • (2012) Frontiers in Psychiatry , vol.3 , pp. 1-14
    • Wolf, A.1    Bauer, B.2    Hartz, A.M.S.3
  • 55
    • 84907529329 scopus 로고    scopus 로고
    • Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary
    • H.-G. G. Bernstein, G. Hölzl, H. Dobrowolny et al., “Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary,” Mechanisms of Ageing and Development, vol. 141-142, pp. 12–21, 2014.
    • (2014) Mechanisms of Ageing and Development , vol.141-142 , pp. 12-21
    • Bernstein, H.-G.G.1    Hölzl, G.2    Dobrowolny, H.3
  • 56
    • 84862192063 scopus 로고    scopus 로고
    • Choroid plexus transport: Gene deletion studies
    • R. F. Keep and D. E. Smith, “Choroid plexus transport: gene deletion studies,” Fluids and Barriers of the CNS, vol. 8, no. 1, p. 26, 2011.
    • (2011) Fluids and Barriers of The CNS , vol.8 , Issue.1 , pp. 26
    • Keep, R.F.1    Smith, D.E.2
  • 57
    • 0034214069 scopus 로고    scopus 로고
    • Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes
    • X. Declèves, A. Regina, J. L. Laplanche et al., “Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes,” Journal of Neuroscience Research, vol. 60, no. 5, pp. 594–601, 2000.
    • (2000) Journal of Neuroscience Research , vol.60 , Issue.5 , pp. 594-601
    • Declèves, X.1    Regina, A.2    Laplanche, J.L.3
  • 58
    • 2442673340 scopus 로고    scopus 로고
    • Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines
    • P. T. Ronaldson, G. Lee, S. Dallas, and R. Bendayan, “Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines,” Pharmaceutical Research, vol. 21, no. 5, pp. 811–818, 2004.
    • (2004) Pharmaceutical Research , vol.21 , Issue.5 , pp. 811-818
    • Ronaldson, P.T.1    Lee, G.2    Dallas, S.3    Bendayan, R.4
  • 59
    • 2042451616 scopus 로고    scopus 로고
    • Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures
    • P. T. Ronaldson, M. Bendayan, D. Gingras, M. Piquette-Miller, and R. Bendayan, “Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures,” Journal of Neurochemistry, vol. 89, no. 3, pp. 788–800, 2004.
    • (2004) Journal of Neurochemistry , vol.89 , Issue.3 , pp. 788-800
    • Ronaldson, P.T.1    Bendayan, M.2    Gingras, D.3    Piquette-Miller, M.4    Bendayan, R.5
  • 60
    • 0037038131 scopus 로고    scopus 로고
    • Glial cells express multiple ATP binding cassette proteins which are involved in ATP release
    • P. Ballerini, P. Di Iorio, R. Ciccarelli et al., “Glial cells express multiple ATP binding cassette proteins which are involved in ATP release,” Neuroreport, vol. 13, no. 14, pp. 1789–1792, 2002.
    • (2002) Neuroreport , vol.13 , Issue.14 , pp. 1789-1792
    • Ballerini, P.1    Di Iorio, P.2    Ciccarelli, R.3
  • 61
    • 1542548173 scopus 로고    scopus 로고
    • P-glycoprotein and caveolin-1α in endothelium and astrocytes of primate brain
    • F. Schlachetzki and W. M. Pardridge, “P-glycoprotein and caveolin-1α in endothelium and astrocytes of primate brain,” Neuroreport, vol. 14, no. 16, pp. 2041–2046, 2003.
    • (2003) Neuroreport , vol.14 , Issue.16 , pp. 2041-2046
    • Schlachetzki, F.1    Pardridge, W.M.2
  • 63
    • 59849129439 scopus 로고    scopus 로고
    • ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ ABCG2) expression in the developing human CNS
    • M. Daood, C. Tsai, M. Ahdab-Barmada, and J. F. Watchko, “ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ ABCG2) expression in the developing human CNS,” Neuro-pediatrics, vol. 39, no. 04, pp. 211–218, 2008.
    • (2008) Neuro-Pediatrics , vol.39 , Issue.4 , pp. 211-218
    • Daood, M.1    Tsai, C.2    Ahdab-Barmada, M.3    Watchko, J.F.4
  • 64
    • 16244367423 scopus 로고    scopus 로고
    • Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables
    • H. Volk, H. Potschka, and W. Löscher, “Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables,” Journal of Histochemistry & Cytochemistry, vol. 53, no. 4, pp. 517–531, 2005.
    • (2005) Journal of Histochemistry & Cytochemistry , vol.53 , Issue.4 , pp. 517-531
    • Volk, H.1    Potschka, H.2    Löscher, W.3
  • 65
    • 0347033287 scopus 로고    scopus 로고
    • Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors
    • E. Aronica, J. A. Gorter, G. H. Jansen et al., “Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors,” Neuroscience, vol. 118, no. 2, pp. 417–429, 2003.
    • (2003) Neuroscience , vol.118 , Issue.2 , pp. 417-429
    • Aronica, E.1    Gorter, J.A.2    Jansen, G.H.3
  • 66
    • 34547699433 scopus 로고    scopus 로고
    • Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia
    • H. Ak, B. Ay, T. Tanriverdi et al., “Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia,” Seizure, vol. 16, no. 6, pp. 493–503, 2007.
    • (2007) Seizure , vol.16 , Issue.6 , pp. 493-503
    • Ak, H.1    Ay, B.2    Tanriverdi, T.3
  • 67
    • 1242298755 scopus 로고    scopus 로고
    • Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization
    • A. J. Ramos, A. Lazarowski, M. J. Villar, and A. Brusco, “Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization,” Cellular and Molecular Neurobiology, vol. 24, no. 1, pp. 101–107, 2004.
    • (2004) Cellular and Molecular Neurobiology , vol.24 , Issue.1 , pp. 101-107
    • Ramos, A.J.1    Lazarowski, A.2    Villar, M.J.3    Brusco, A.4
  • 68
    • 0036849351 scopus 로고    scopus 로고
    • P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following fas ligation
    • A. A. Ruefli, K. M. Tainton, P. K. Darcy, M. J. Smyth, and R. W. Johnstone, “P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation,” Cell Death & Differentiation, vol. 9, no. 11, pp. 1266–1272, 2002.
    • (2002) Cell Death & Differentiation , vol.9 , Issue.11 , pp. 1266-1272
    • Ruefli, A.A.1    Tainton, K.M.2    Darcy, P.K.3    Smyth, M.J.4    Johnstone, R.W.5
  • 69
    • 0035992274 scopus 로고    scopus 로고
    • P-glycoprotein in acute myeloid leukaemia: Therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype
    • M. Pallis, J. Turzanski, Y. Higashi, and N. Russell, “P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype,” Leukemia & Lymphoma, vol. 43, no. 6, pp. 1221–1228, 2002.
    • (2002) Leukemia & Lymphoma , vol.43 , Issue.6 , pp. 1221-1228
    • Pallis, M.1    Turzanski, J.2    Higashi, Y.3    Russell, N.4
  • 70
    • 12344336357 scopus 로고    scopus 로고
    • P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway
    • J. Turzanski, M. Grundy, S. Shang, N. Russell, and M. Pallis, “P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway,” Experimental Hematology, vol. 33, no. 1, pp. 62–72, 2005.
    • (2005) Experimental Hematology , vol.33 , Issue.1 , pp. 62-72
    • Turzanski, J.1    Grundy, M.2    Shang, S.3    Russell, N.4    Pallis, M.5
  • 71
    • 0014767029 scopus 로고
    • Cellular resistance to actinomy-cin d in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies
    • J. L. Biedler and H. Riehm, “Cellular resistance to actinomy-cin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies,” Cancer Research, vol. 30, no. 4, pp. 1174–1184, 1970.
    • (1970) Cancer Research , vol.30 , Issue.4 , pp. 1174-1184
    • Biedler, J.L.1    Riehm, H.2
  • 72
    • 12744253433 scopus 로고    scopus 로고
    • Modulation of P-glycoprotein transport function at the blood-brain barrier
    • B. Bauer, A. M. S. Hartz, G. Fricker, and D. S. Miller, “Modulation of P-glycoprotein transport function at the blood-brain barrier,” Experimental Biology and Medicine, vol. 230, no. 2, pp. 118–127, 2005.
    • (2005) Experimental Biology and Medicine , vol.230 , Issue.2 , pp. 118-127
    • Bauer, B.1    Hartz, A.M.S.2    Fricker, G.3    Miller, D.S.4
  • 73
    • 33749488939 scopus 로고    scopus 로고
    • Human multidrug resistance ABCB and ABCG transporters: Participation in a chemoimmunity defense system
    • B. Sarkadi, L. Homolya, G. Szakács, and A. Váradi, “Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system,” Physiological Reviews, vol. 86, no. 4, pp. 1179–1236, 2006.
    • (2006) Physiological Reviews , vol.86 , Issue.4 , pp. 1179-1236
    • Sarkadi, B.1    Homolya, L.2    Szakács, G.3    Váradi, A.4
  • 74
    • 0027524642 scopus 로고
    • In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarbonxamide derivative
    • F. Hyafil, C. Vergely, P. Du Vignaud, and T. Grand-Perret, “In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarbonxamide derivative,” Cancer Research, vol. 53, no. 19, pp. 4595–4602, 1993.
    • (1993) Cancer Research , vol.53 , Issue.19 , pp. 4595-4602
    • Hyafil, F.1    Vergely, C.2    Du Vignaud, P.3    Grand-Perret, T.4
  • 75
    • 0029809499 scopus 로고    scopus 로고
    • Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
    • A. H. Dantzig, R. L. Shepard, J. Cao et al., “Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979,” Cancer Research, vol. 56, no. 18, pp. 4171–4179, 1996.
    • (1996) Cancer Research , vol.56 , Issue.18 , pp. 4171-4179
    • Dantzig, A.H.1    Shepard, R.L.2    Cao, J.3
  • 76
    • 30344487254 scopus 로고    scopus 로고
    • Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs
    • P. Breedveld, J. H. Beijnen, and J. H. M. Schellens, “Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs,” Trends in Pharmacological Sciences, vol. 27, no. 1, pp. 17–24, 2006.
    • (2006) Trends in Pharmacological Sciences , vol.27 , Issue.1 , pp. 17-24
    • Breedveld, P.1    Beijnen, J.H.2    Schellens, J.H.M.3
  • 77
    • 33745660599 scopus 로고    scopus 로고
    • The influence of P-glycoprotein on cerebral and hepatic concentrations of nortriptyline and its metabolites
    • T. B. Ejsing, J. Hasselstrøm, and K. Linnet, “The influence of P-glycoprotein on cerebral and hepatic concentrations of nortriptyline and its metabolites,” Drug Metabolism and Drug Interactions, vol. 21, no. 3-4, pp. 139–162, 2006.
    • (2006) Drug Metabolism and Drug Interactions , vol.21 , Issue.3-4 , pp. 139-162
    • Ejsing, T.B.1    Hasselstrøm, J.2    Linnet, K.3
  • 78
    • 34548134497 scopus 로고    scopus 로고
    • Increased uptake of quinine into the brain by inhibition of P-glycoprotein
    • E. Pussard, M. Merzouk, and H. Barennes, “Increased uptake of quinine into the brain by inhibition of P-glycoprotein,” European Journal of Pharmaceutical Sciences, vol. 32, no. 2, pp. 123–127, 2007.
    • (2007) European Journal of Pharmaceutical Sciences , vol.32 , Issue.2 , pp. 123-127
    • Pussard, E.1    Merzouk, M.2    Barennes, H.3
  • 79
    • 33846081034 scopus 로고    scopus 로고
    • P-glycoprotein-mediated transport of oxytetracycline in the caco-2 cell model
    • J. Schrickx and J. Fink-Gremmels, “P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model,” Journal of Veterinary Pharmacology and Therapeutics, vol. 30, no. 1, pp. 25–31, 2007.
    • (2007) Journal of Veterinary Pharmacology and Therapeutics , vol.30 , Issue.1 , pp. 25-31
    • Schrickx, J.1    Fink-Gremmels, J.2
  • 80
    • 0023237840 scopus 로고
    • Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients
    • R. F. Ozols, R. E. Cunnion, R. W. Klecker Jr et al., “Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients,” Journal of Clinical Oncology, vol. 5, no. 4, pp. 641–647, 1987.
    • (1987) Journal of Clinical Oncology , vol.5 , Issue.4 , pp. 641-647
    • Ozols, R.F.1    Cunnion, R.E.2    Klecker, R.W.3
  • 81
    • 84879415192 scopus 로고    scopus 로고
    • Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: The ITC evidence-based position
    • J. C. Kalvass, J. W. Polli, D. L. Bourdet et al., “Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position,” Clinical Pharmacology & Therapeutics, vol. 94, no. 1, pp. 80–94, 2013.
    • (2013) Clinical Pharmacology & Therapeutics , vol.94 , Issue.1 , pp. 80-94
    • Kalvass, J.C.1    Polli, J.W.2    Bourdet, D.L.3
  • 82
    • 46649085260 scopus 로고    scopus 로고
    • Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA
    • A. L. Bartels, A. T. M. Willemsen, R. Kortekaas et al., “Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA,” Journal of Neural Transmission, vol. 115, no. 7, pp. 1001–1009, 2008.
    • (2008) Journal of Neural Transmission , vol.115 , Issue.7 , pp. 1001-1009
    • Bartels, A.L.1    Willemsen, A.T.M.2    Kortekaas, R.3
  • 83
    • 84895591529 scopus 로고    scopus 로고
    • Implication of P-glycoprotein in formation of depression-prone personality: Association study between the C3435T MDR1 gene polymorphism and interpersonal sensitivity
    • M. Enokido, A. Suzuki, R. Sadahiro et al., “Implication of P-glycoprotein in formation of depression-prone personality: association study between the C3435T MDR1 gene polymorphism and interpersonal sensitivity,” Neuropsychobiology, vol. 69, no. 2, pp. 89–94, 2014.
    • (2014) Neuropsychobiology , vol.69 , Issue.2 , pp. 89-94
    • Enokido, M.1    Suzuki, A.2    Sadahiro, R.3
  • 84
    • 84896098989 scopus 로고    scopus 로고
    • Novel and functional ABCB1 gene variant in sporadic Parkinson’s disease
    • Y. Li, Y. Li, S. Pang et al., “Novel and functional ABCB1 gene variant in sporadic Parkinson’s disease,” Neuroscience Letters, vol. 566, pp. 61–66, 2014.
    • (2014) Neuroscience Letters , vol.566 , pp. 61-66
    • Li, Y.1    Li, Y.2    Pang, S.3
  • 85
    • 84891864712 scopus 로고    scopus 로고
    • Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals
    • M. Santos, S. Carvalho, L. Lima et al., “Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals,” Genetic Testing and Molecular Biomarkers, vol. 18, no. 1, pp. 12–19, 2014.
    • (2014) Genetic Testing and Molecular Biomarkers , vol.18 , Issue.1 , pp. 12-19
    • Santos, M.1    Carvalho, S.2    Lima, L.3
  • 86
    • 0020080046 scopus 로고
    • Competition between transport of glutathione disulfide (GSSG) and glutathione S-conjugates from perfused rat liver into bile
    • T. P. Akerboom, M. Bilzer, and H. Sies, “Competition between transport of glutathione disulfide (GSSG) and glutathione S-conjugates from perfused rat liver into bile,” FEBS Letters, vol. 140, no. 1, pp. 73–76, 1982.
    • (1982) FEBS Letters , vol.140 , Issue.1 , pp. 73-76
    • Akerboom, T.P.1    Bilzer, M.2    Sies, H.3
  • 87
    • 0021246650 scopus 로고
    • Biliary transport of glutathione disulfide studied with isolated rat-liver canalicular-membrane vesicles
    • T. Akerboom, M. Inoue, H. Sies, R. Kinne, and I. M. Arias, “Biliary transport of glutathione disulfide studied with isolated rat-liver canalicular-membrane vesicles,” European Journal of Biochemistry, vol. 141, no. 1, pp. 211–215, 1984.
    • (1984) European Journal of Biochemistry , vol.141 , Issue.1 , pp. 211-215
    • Akerboom, T.1    Inoue, M.2    Sies, H.3    Kinne, R.4    Arias, I.M.5
  • 88
    • 30144440842 scopus 로고    scopus 로고
    • Multidrug resistance protein 1-mediated export of glutathione and glutathione disulfide from brain astrocytes
    • J. Hirrlinger and R. Dringen, “Multidrug resistance protein 1-mediated export of glutathione and glutathione disulfide from brain astrocytes,” Methods in Enzymology, vol. 400, pp. 395–409, 2005.
    • (2005) Methods in Enzymology , vol.400 , pp. 395-409
    • Hirrlinger, J.1    Dringen, R.2
  • 89
    • 48249151774 scopus 로고    scopus 로고
    • HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells
    • P. T. Ronaldson and R. Bendayan, “HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells,” Journal of Neurochemistry, vol. 106, no. 3, pp. 1298–1313, 2008.
    • (2008) Journal of Neurochemistry , vol.106 , Issue.3 , pp. 1298-1313
    • Ronaldson, P.T.1    Bendayan, R.2
  • 91
    • 0035145779 scopus 로고    scopus 로고
    • The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress
    • J. Hirrlinger, J. König, D. Keppler, J. Lindenau, J. B. Schulz, and R. Dringen, “The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress,” Journal of Neurochemistry, vol. 76, no. 2, pp. 627–636, 2001.
    • (2001) Journal of Neurochemistry , vol.76 , Issue.2 , pp. 627-636
    • Hirrlinger, J.1    König, J.2    Keppler, D.3    Lindenau, J.4    Schulz, J.B.5    Dringen, R.6
  • 92
    • 0035669389 scopus 로고    scopus 로고
    • Overex-pression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy
    • S. M. Dombrowski, S. Y. Desai, M. Marroni et al., “Overex-pression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy,” Epilepsia, vol. 42, no. 12, pp. 1501–1506, 2001.
    • (2001) Epilepsia , vol.42 , Issue.12 , pp. 1501-1506
    • Dombrowski, S.M.1    Desai, S.Y.2    Marroni, M.3
  • 93
    • 48749119557 scopus 로고    scopus 로고
    • Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier
    • A. M. S. Hartz, B. Bauer, M. L. Block, J.-S. Hong, and D. S. Miller, “Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier,” FASEB Journal, vol. 22, no. 8, pp. 2723–2733, 2008.
    • (2008) FASEB Journal , vol.22 , Issue.8 , pp. 2723-2733
    • Hartz, A.M.S.1    Bauer, B.2    Block, M.L.3    Hong, J.-S.4    Miller, D.S.5
  • 94
    • 33645340038 scopus 로고    scopus 로고
    • Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia
    • A. Spudich, E. Kilic, H. Xing et al., “Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia,” Nature Neuroscience, vol. 9, no. 4, pp. 487-488, 2006.
    • (2006) Nature Neuroscience , vol.9 , Issue.4 , pp. 487-488
    • Spudich, A.1    Kilic, E.2    Xing, H.3
  • 96
    • 84897442309 scopus 로고    scopus 로고
    • Signaling pathways that regulate basal ABC transporter activity at the blood-brain barrier
    • D. S. Miller and R. E. Cannon, “Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier,” Current Pharmaceutical Design, vol. 20, no. 10, pp. 1463–1471, 2014.
    • (2014) Current Pharmaceutical Design , vol.20 , Issue.10 , pp. 1463-1471
    • Miller, D.S.1    Cannon, R.E.2
  • 97
    • 0034283387 scopus 로고    scopus 로고
    • Physiological oxygen tensions modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures
    • K.I.Hirsch-Ernst,T.Kietzmann,C.Ziemann,K.Jungermann, and G. F. Kahl, “Physiological oxygen tensions modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures,” Biochemical Journal, vol. 350, no. 2, pp. 443–451, 2000.
    • (2000) Biochemical Journal , vol.350 , Issue.2 , pp. 443-451
    • Hirsch-Ernst, K.I.1    Kietzmann, T.2    Ziemann, C.3    Jungermann, K.4    Kahl, G.F.5
  • 98
    • 0034695660 scopus 로고    scopus 로고
    • Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-κB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis
    • F. Thévenod, J. M. Friedmann, A. D. Katsen, and I. A. Hauser, “Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-κB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis,” Journal of Biological Chemistry, vol. 275, no. 3, pp. 1887–1896, 2000.
    • (2000) Journal of Biological Chemistry , vol.275 , Issue.3 , pp. 1887-1896
    • Thévenod, F.1    Friedmann, J.M.2    Katsen, A.D.3    Hauser, I.A.4
  • 99
    • 0034650814 scopus 로고    scopus 로고
    • Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids
    • M. Wartenberg, K. Fischer, J. Hescheler, and H. Sauer, “Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids,” International Journal of Cancer, vol. 85, no. 2, pp. 267–274, 2000.
    • (2000) International Journal of Cancer , vol.85 , Issue.2 , pp. 267-274
    • Wartenberg, M.1    Fischer, K.2    Hescheler, J.3    Sauer, H.4
  • 100
    • 0036269538 scopus 로고    scopus 로고
    • P-glycoprotein expression in rat brain endothelial cells: Evidence for regulation by transient oxidative stress
    • R. A. Felix and M. A. Barrand, “P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress,” Journal of Neurochemistry, vol. 80, no. 1, pp. 64–72, 2002.
    • (2002) Journal of Neurochemistry , vol.80 , Issue.1 , pp. 64-72
    • Felix, R.A.1    Barrand, M.A.2
  • 101
    • 33746925983 scopus 로고    scopus 로고
    • Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells
    • H. Hong, Y. Lu, Z.-N. Ji, and G.-Q. Liu, “Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells,” Journal of Neurochemistry, vol. 98, no. 5, pp. 1465–1473, 2006.
    • (2006) Journal of Neurochemistry , vol.98 , Issue.5 , pp. 1465-1473
    • Hong, H.1    Lu, Y.2    Ji, Z.-N.3    Liu, G.-Q.4
  • 102
    • 0348049803 scopus 로고    scopus 로고
    • Reactive oxygen species in oncogenic transformation
    • L. Behrend, G. Henderson, and R. M. Zwacka, “Reactive oxygen species in oncogenic transformation,” Biochemical Society Transactions, vol. 31, no. 6, pp. 1441–1444, 2003.
    • (2003) Biochemical Society Transactions , vol.31 , Issue.6 , pp. 1441-1444
    • Behrend, L.1    Henderson, G.2    Zwacka, R.M.3
  • 103
    • 85028817942 scopus 로고    scopus 로고
    • Britanin ameliorates cerebral ischemia-reperfusion injury by inducing the Nrf2 protective pathway
    • G. Wu, L. Zhu, X. Yuan et al., “Britanin ameliorates cerebral ischemia-reperfusion injury by inducing the Nrf2 protective pathway,” Antioxidants & Redox Signaling, vol. 27, no. 11, pp. 754–768, 2017.
    • (2017) Antioxidants & Redox Signaling , vol.27 , Issue.11 , pp. 754-768
    • Wu, G.1    Zhu, L.2    Yuan, X.3
  • 104
    • 84994008595 scopus 로고    scopus 로고
    • Sulforaphane activates the cerebral vascular Nrf2-ARE pathway and suppresses inflammation to attenuate cerebral vasospasm in rat with subarachnoid hemorrhage
    • X. Zhao, L. Wen, M. Dong, and X. Lu, “Sulforaphane activates the cerebral vascular Nrf2- ARE pathway and suppresses inflammation to attenuate cerebral vasospasm in rat with subarachnoid hemorrhage,” Brain Research, vol. 1653, pp. 1–7, 2016.
    • (2016) Brain Research , vol.1653 , pp. 1-7
    • Zhao, X.1    Wen, L.2    Dong, M.3    Lu, X.4
  • 105
    • 84870902532 scopus 로고    scopus 로고
    • Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
    • M. Zhang, C. An, Y. Gao, R. K. Leak, J. Chen, and F. Zhang, “Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection,” Progress in Neurobiology, vol. 100, pp. 30–47, 2013.
    • (2013) Progress in Neurobiology , vol.100 , pp. 30-47
    • Zhang, M.1    An, C.2    Gao, Y.3    Leak, R.K.4    Chen, J.5    Zhang, F.6
  • 106
    • 84910123251 scopus 로고    scopus 로고
    • Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson’s disease
    • F. Morroni, G. Sita, A. Tarozzi, G. Cantelli-Forti, and P. Hrelia, “Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson’s disease,” Brain Research, vol. 1589, pp. 93–104, 2014.
    • (2014) Brain Research , vol.1589 , pp. 93-104
    • Morroni, F.1    Sita, G.2    Tarozzi, A.3    Cantelli-Forti, G.4    Hrelia, P.5
  • 107
    • 85003944875 scopus 로고    scopus 로고
    • Protective effect of 3H-1, 2-dithiole-3-thione on cellular model of Alzheimer’s disease involves Nrf2/ARE signaling pathway
    • L. Wang, M. Wang, J. Hu et al., “Protective effect of 3H-1, 2-dithiole-3-thione on cellular model of Alzheimer’s disease involves Nrf2/ARE signaling pathway,” European Journal of Pharmacology, vol. 795, pp. 115–123, 2017.
    • (2017) European Journal of Pharmacology , vol.795 , pp. 115-123
    • Wang, L.1    Wang, M.2    Hu, J.3
  • 108
    • 84902436456 scopus 로고    scopus 로고
    • Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers
    • X. Wang, C. R. Campos, J. C. Peart et al., “Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers,” The Journal of Neuroscience, vol. 34, no. 25, pp. 8585–8593, 2014.
    • (2014) The Journal of Neuroscience , vol.34 , Issue.25 , pp. 8585-8593
    • Wang, X.1    Campos, C.R.2    Peart, J.C.3
  • 109
    • 78149488153 scopus 로고    scopus 로고
    • Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis
    • S. W. Pimplikar, R. A. Nixon, N. K. Robakis, J. Shen, and L.H. Tsai, “Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis,” The Journal of Neuroscience, vol. 30, no. 45, pp. 14946–14954, 2010.
    • (2010) The Journal of Neuroscience , vol.30 , Issue.45 , pp. 14946-14954
    • Pimplikar, S.W.1    Nixon, R.A.2    Robakis, N.K.3    Shen, J.4    Tsai, L.H.5
  • 110
    • 80051669619 scopus 로고    scopus 로고
    • The projected effect of risk factor reduction on Alzheimer’s disease prevalence
    • D. E. Barnes and K. Yaffe, “The projected effect of risk factor reduction on Alzheimer’s disease prevalence,” The Lancet Neurology, vol. 10, no. 9, pp. 819–828, 2011.
    • (2011) The Lancet Neurology , vol.10 , Issue.9 , pp. 819-828
    • Barnes, D.E.1    Yaffe, K.2
  • 111
    • 78149255128 scopus 로고    scopus 로고
    • Low-density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β-peptide elimination from the brain
    • B. V. Zlokovic, R. Deane, A. P. Sagare, R. D. Bell, and E. A. Winkler, “Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β-peptide elimination from the brain,” Journal of Neurochemistry, vol. 115, no. 5, pp. 1077–1089, 2010.
    • (2010) Journal of Neurochemistry , vol.115 , Issue.5 , pp. 1077-1089
    • Zlokovic, B.V.1    Deane, R.2    Sagare, A.P.3    Bell, R.D.4    Winkler, E.A.5
  • 112
    • 0035112889 scopus 로고    scopus 로고
    • Β-amyloid efflux mediated by P-glycoprotein
    • F. C. Lam, R. Liu, P. Lu et al., “β-amyloid efflux mediated by P-glycoprotein,” Journal of Neurochemistry, vol. 76, no. 4, pp. 1121–1128, 2001.
    • (2001) Journal of Neurochemistry , vol.76 , Issue.4 , pp. 1121-1128
    • Lam, F.C.1    Liu, R.2    Lu, P.3
  • 113
    • 0037703255 scopus 로고    scopus 로고
    • RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
    • R. Deane, S. Du Yan, R. K. Submamaryan et al., “RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain,” Nature Medicine, vol. 9, no. 7, pp. 907–913, 2003.
    • (2003) Nature Medicine , vol.9 , Issue.7 , pp. 907-913
    • Deane, R.1    Du Yan, S.2    Submamaryan, R.K.3
  • 114
    • 77951078680 scopus 로고    scopus 로고
    • Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer’s disease
    • A. M. S. Hartz, D. S. Miller, and B. Bauer, “Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer’s disease,” Molecular Pharmacology, vol. 77, no. 5, pp. 715–723, 2010.
    • (2010) Molecular Pharmacology , vol.77 , Issue.5 , pp. 715-723
    • Hartz, A.M.S.1    Miller, D.S.2    Bauer, B.3
  • 115
    • 78650659385 scopus 로고    scopus 로고
    • Apical-to-basolat-eral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein
    • P. Candela, F. Gosselet, J. Saint-Pol et al., “Apical-to-basolat-eral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein,” Journal of Alzheimer's Disease, vol. 22, no. 3, pp. 849–859, 2010.
    • (2010) Journal of Alzheimer'S Disease , vol.22 , Issue.3 , pp. 849-859
    • Candela, P.1    Gosselet, F.2    Saint-Pol, J.3
  • 116
    • 77958117519 scopus 로고    scopus 로고
    • Is P-glycoprotein involved in amyloid-β elimination across the blood–brain barrier in Alzheimer’s disease?
    • S. Ohtsuki, S. Ito, and T. Terasaki, “Is P-glycoprotein involved in amyloid-β elimination across the blood–brain barrier in Alzheimer’s disease?,” Clinical Pharmacology & Therapeutics, vol. 88, no. 4, pp. 443–445, 2010.
    • (2010) Clinical Pharmacology & Therapeutics , vol.88 , Issue.4 , pp. 443-445
    • Ohtsuki, S.1    Ito, S.2    Terasaki, T.3
  • 117
    • 0033609856 scopus 로고    scopus 로고
    • The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface
    • T. W. Loo and D. M. Clarke, “The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface,” Journal of Biological Chemistry, vol. 274, no. 35, pp. 24759–24765, 1999.
    • (1999) Journal of Biological Chemistry , vol.274 , Issue.35 , pp. 24759-24765
    • Loo, T.W.1    Clarke, D.M.2
  • 118
    • 84958817297 scopus 로고    scopus 로고
    • Aβ40 reduces P-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway
    • A. M. S. Hartz, Y. Zhong, A. Wolf, H. LeVine, D. S. Miller, and B. Bauer, “Aβ40 reduces P-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway,” The Journal of Neuroscience, vol. 36, no. 6, pp. 1930–1941, 2016.
    • (2016) The Journal of Neuroscience , vol.36 , Issue.6 , pp. 1930-1941
    • Hartz, A.M.S.1    Zhong, Y.2    Wolf, A.3    LeVine, H.4    Miller, D.S.5    Bauer, B.6
  • 119
    • 0036797713 scopus 로고    scopus 로고
    • Deposition of Alzheimer’s β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly nondemented humans
    • S. Vogelgesang, I. Cascorbi, E. Schroeder et al., “Deposition of Alzheimer’s β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly nondemented humans,” Pharmacogenetics and Genomics, vol. 12, no. 7, pp. 535–541, 2002.
    • (2002) Pharmacogenetics and Genomics , vol.12 , Issue.7 , pp. 535-541
    • Vogelgesang, S.1    Cascorbi, I.2    Schroeder, E.3
  • 120
    • 84875319920 scopus 로고    scopus 로고
    • Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer’s disease patients: Effect of polymorphisms in the ABCB1 gene
    • D. M. van Assema, M. Lubberink, P. Rizzu et al., “Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer’s disease patients: effect of polymorphisms in the ABCB1 gene,” European Journal of Nuclear Medicine and Molecular Imaging Research, vol. 2, no. 1, p. 57, 2012.
    • (2012) European Journal of Nuclear Medicine and Molecular Imaging Research , vol.2 , Issue.1 , pp. 57
    • Van Assema, D.M.1    Lubberink, M.2    Rizzu, P.3
  • 121
    • 77957352509 scopus 로고    scopus 로고
    • ABC efflux transporters in brain vasculature of Alzheimer’s subjects
    • H. C. Wijesuriya, J. Y. Bullock, R. L. Faull, S. B. Hladky, and M. A. Barrand, “ABC efflux transporters in brain vasculature of Alzheimer’s subjects,” Brain Research, vol. 1358, pp. 228–238, 2010.
    • (2010) Brain Research , vol.1358 , pp. 228-238
    • Wijesuriya, H.C.1    Bullock, J.Y.2    Faull, R.L.3    Hladky, S.B.4    Barrand, M.A.5
  • 123
    • 80053386106 scopus 로고    scopus 로고
    • Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells
    • K. D. Kania, H. C. Wijesuriya, S. B. Hladky, and M. A. Barrand, “Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells,” Brain Research, vol. 1418, pp. 1–11, 2011.
    • (2011) Brain Research , vol.1418 , pp. 1-11
    • Kania, K.D.1    Wijesuriya, H.C.2    Hladky, S.B.3    Barrand, M.A.4
  • 124
    • 84903761512 scopus 로고    scopus 로고
    • 1-42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling
    • 1-42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling,” Cell Death & Disease, vol. 5, no. 6, article e1299, 2014.
    • (2014) Cell Death & Disease , vol.5 , Issue.6 , pp. e1299
    • Park, R.1    Kook, S.-Y.2    Park, J.-C.3    Mook-Jung, I.4
  • 125
    • 84856429045 scopus 로고    scopus 로고
    • Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy
    • A. M. S. Hartz, B. Bauer, E. L. B. Soldner et al., “Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy,” Stroke, vol. 43, no. 2, pp. 514–523, 2012.
    • (2012) Stroke , vol.43 , Issue.2 , pp. 514-523
    • Hartz, A.M.S.1    Bauer, B.2    Soldner, E.L.B.3
  • 126
    • 85029708875 scopus 로고    scopus 로고
    • Blood-brain barrier dysfunction and the pathogenesis of Alzheimer’s disease
    • Y. Yamazaki and T. Kanekiyo, “Blood-brain barrier dysfunction and the pathogenesis of Alzheimer’s disease,” International Journal of Molecular Science, vol. 18, no. 9, p. 1965, 2017.
    • (2017) International Journal of Molecular Science , vol.18 , Issue.9 , pp. 1965
    • Yamazaki, Y.1    Kanekiyo, T.2
  • 127
    • 84863011816 scopus 로고    scopus 로고
    • TLR2 is a primary receptor for Alzheimer’s amyloid β peptide to trigger neuroinflammatory activation
    • S. Liu, Y. Liu, W. Hao et al., “TLR2 is a primary receptor for Alzheimer’s amyloid β peptide to trigger neuroinflammatory activation,” The Journal of Immunology, vol. 188, no. 3, pp. 1098–1107, 2012.
    • (2012) The Journal of Immunology , vol.188 , Issue.3 , pp. 1098-1107
    • Liu, S.1    Liu, Y.2    Hao, W.3
  • 128
    • 0034612175 scopus 로고    scopus 로고
    • Inflammation and Alzheimer’s disease
    • H. Akiyama, S. Barger, S. Barnum et al., “Inflammation and Alzheimer’s disease,” Neurobiology of Aging, vol. 21, no. 3, pp. 383–421, 2000.
    • (2000) Neurobiology of Aging , vol.21 , Issue.3 , pp. 383-421
    • Akiyama, H.1    Barger, S.2    Barnum, S.3
  • 129
    • 77954012943 scopus 로고    scopus 로고
    • P-glycoprotein acts as an immunomodulator during neuroinflammation
    • G. Kooij, R. Backer, J. J. Koning et al., “P-glycoprotein acts as an immunomodulator during neuroinflammation,” PLoS One, vol. 4, no. 12, p. e8212, 2009.
    • (2009) PLoS One , vol.4 , Issue.12 , pp. e8212
    • Kooij, G.1    Backer, R.2    Koning, J.J.3
  • 130
    • 34547102265 scopus 로고    scopus 로고
    • Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment
    • D. A. Butterfield, T. Reed, S. F. Newman, and R. Sultana, “Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment,” Free Radical Biology and Medicine, vol. 43, no. 5, pp. 658–677, 2007.
    • (2007) Free Radical Biology and Medicine , vol.43 , Issue.5 , pp. 658-677
    • Butterfield, D.A.1    Reed, T.2    Newman, S.F.3    Sultana, R.4
  • 131
    • 0032983334 scopus 로고    scopus 로고
    • 2 forming NADPH oxidase in microglia, monocytes, and neutrophils. a possible inflammatory mechanism of neuronal damage in Alzheimer’s disease
    • 2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer’s disease,” The Journal of Biological Chemistry, vol. 274, no. 22, pp. 15493–15499, 1999.
    • (1999) The Journal of Biological Chemistry , vol.274 , Issue.22 , pp. 15493-15499
    • Bianca, V.D.1    Dusi, S.2    Bianchini, E.3    Dal Prà, I.4    Rossi, F.5
  • 132
    • 77950131689 scopus 로고    scopus 로고
    • Oxidative stress upregulates presenilin 1 in lipid rafts in neuronal cells
    • A. Oda, A. Tamaoka, and W. Araki, “Oxidative stress upregulates presenilin 1 in lipid rafts in neuronal cells,” Journal of Neuroscience Research, vol. 88, no. 5, pp. 1137–1145, 2010.
    • (2010) Journal of Neuroscience Research , vol.88 , Issue.5 , pp. 1137-1145
    • Oda, A.1    Tamaoka, A.2    Araki, W.3
  • 133
    • 84863005570 scopus 로고    scopus 로고
    • Lipopolysaccharide impairs amyloid beta efflux from brain: Altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier
    • M. A. Erickson, P. E. Hartvigson, Y. Morofuji, J. B. Owen, D. A. Butterfield, and W. A. Banks, “Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier,” Journal of Neuroinflammation, vol. 9, p. 150, 2012.
    • (2012) Journal of Neuroinflammation , vol.9 , pp. 150
    • Erickson, M.A.1    Hartvigson, P.E.2    Morofuji, Y.3    Owen, J.B.4    Butterfield, D.A.5    Banks, W.A.6
  • 134
  • 135
    • 85020305533 scopus 로고    scopus 로고
    • Lack of P-glycoprotein results in impairment of removal of beta-amyloid and increased intraparenchymal cerebral amyloid angiopathy after active immunization in a transgenic mouse model of Alzheimer’s disease
    • S. Bruckmann, A. Brenn, M. Grube et al., “Lack of P-glycoprotein results in impairment of removal of beta-amyloid and increased intraparenchymal cerebral amyloid angiopathy after active immunization in a transgenic mouse model of Alzheimer’s disease,” Current Pharmaceutical Design, vol. 14, no. 6, pp. 656–667, 2017.
    • (2017) Current Pharmaceutical Design , vol.14 , Issue.6 , pp. 656-667
    • Bruckmann, S.1    Brenn, A.2    Grube, M.3
  • 136
    • 84952893165 scopus 로고    scopus 로고
    • Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction
    • A. Kumar, M. J. Ekavali, K. Chopra, and D. K. Dhull, “Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction,” Psychopharmacology, vol. 233, no. 1, pp. 137–152, 2016.
    • (2016) Psychopharmacology , vol.233 , Issue.1 , pp. 137-152
    • Kumar, A.1    Ekavali, M.J.2    Chopra, K.3    Dhull, D.K.4
  • 137
    • 84921829329 scopus 로고    scopus 로고
    • Regulation of ABC transporters blood-brain barrier: The good, the bad, and the ugly
    • D. S. Miller, “Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly,” Advances in Cancer Research, vol. 125, pp. 43–70, 2015.
    • (2015) Advances in Cancer Research , vol.125 , pp. 43-70
    • Miller, D.S.1
  • 138
    • 70450246963 scopus 로고    scopus 로고
    • Depletion of Vitamin E increases amyloid β accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease
    • Y. Nishida, S. Ito, S. Ohtsuki et al., “Depletion of Vitamin E increases amyloid β accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease,” Journal of Biological Chemistry, vol. 284, no. 48, pp. 33400–33408, 2009.
    • (2009) Journal of Biological Chemistry , vol.284 , Issue.48 , pp. 33400-33408
    • Nishida, Y.1    Ito, S.2    Ohtsuki, S.3
  • 139
    • 0035933511 scopus 로고    scopus 로고
    • The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity
    • R. E. Watkins, G. B. Wisely, L. B. Moore et al., “The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity,” Science, vol. 292, no. 5525, pp. 2329–2333, 2001.
    • (2001) Science , vol.292 , Issue.5525 , pp. 2329-2333
    • Watkins, R.E.1    Wisely, G.B.2    Moore, L.B.3
  • 140
    • 12144290676 scopus 로고    scopus 로고
    • A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease
    • M. B. Loeb, D. W. Molloy, M. Smieja et al., “A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease,” Journal of the American Geriatrics Society, vol. 52, no. 3, pp. 381–387, 2004.
    • (2004) Journal of The American Geriatrics Society , vol.52 , Issue.3 , pp. 381-387
    • Loeb, M.B.1    Molloy, D.W.2    Smieja, M.3
  • 141
    • 84877120241 scopus 로고    scopus 로고
    • Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: In vitro and in vivo studies
    • A. H. Abuznait, H. Qosa, B. A. Busnena, K. A. El Sayed, and A. Kaddoumi, “Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies,” ACS Chemical Neuroscience, vol. 4, no. 6, pp. 973–982, 2013.
    • (2013) ACS Chemical Neuroscience , vol.4 , Issue.6 , pp. 973-982
    • Abuznait, A.H.1    Qosa, H.2    Busnena, B.A.3    El Sayed, K.A.4    Kaddoumi, A.5
  • 142
    • 84947731754 scopus 로고    scopus 로고
    • Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model
    • H. Qosa, Y. S. Batarseh, M. M. Mohyeldin, K. A. El Sayed, J. N. Keller, and A. Kaddoumi, “Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model,” ACS Chemical Neuroscience, vol. 6, no. 11, pp. 1849–1859, 2015.
    • (2015) ACS Chemical Neuroscience , vol.6 , Issue.11 , pp. 1849-1859
    • Qosa, H.1    Batarseh, Y.S.2    Mohyeldin, M.M.3    El Sayed, K.A.4    Keller, J.N.5    Kaddoumi, A.6
  • 143
    • 84890800604 scopus 로고    scopus 로고
    • St. John’s wort reduces beta-amyloid accumulation in a double transgenic Alzheimer’s disease mouse model-role of P-glycoprotein
    • A. Brenn, M. Grube, G. Jedlitschky et al., “St. John’s wort reduces beta-amyloid accumulation in a double transgenic Alzheimer’s disease mouse model-role of P-glycoprotein,” Brain Pathology, vol. 24, no. 1, pp. 18–24, 2014.
    • (2014) Brain Pathology , vol.24 , Issue.1 , pp. 18-24
    • Brenn, A.1    Grube, M.2    Jedlitschky, G.3
  • 144
    • 79956223783 scopus 로고    scopus 로고
    • 3 up-regulates P-glycoprotein via the Vitamin D receptor and not farnesoid x receptor in both fxr(−/−) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo
    • 3 up-regulates P-glycoprotein via the Vitamin D receptor and not farnesoid X receptor in both fxr(−/−) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 3, pp. 846–859, 2011.
    • (2011) Journal of Pharmacology and Experimental Therapeutics , vol.337 , Issue.3 , pp. 846-859
    • Chow, E.C.Y.1    Durk, M.R.2    Cummins, C.L.3    Pang, K.S.4
  • 145
    • 84870595984 scopus 로고    scopus 로고
    • 3-liganded Vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells
    • 3-liganded Vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells,” Journal of Neurochemistry, vol. 123, no. 6, pp. 944–953, 2012.
    • (2012) Journal of Neurochemistry , vol.123 , Issue.6 , pp. 944-953
    • Durk, M.R.1    Chan, G.N.Y.2    Campos, C.R.3
  • 146
    • 84900993069 scopus 로고    scopus 로고
    • 3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer’s disease
    • 3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer’s disease,” Journal of Neuroscience, vol. 34, no. 21, pp. 7091–7101, 2014.
    • (2014) Journal of Neuroscience , vol.34 , Issue.21 , pp. 7091-7101
    • Durk, M.R.1    Han, K.2    Chow, E.C.Y.3
  • 147
    • 84946555317 scopus 로고    scopus 로고
    • Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship
    • S. Manda, S. Sharma, A. Wani et al., “Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship,” European Journal of Medical Chemistry, vol. 107, pp. 1–11, 2016.
    • (2016) European Journal of Medical Chemistry , vol.107 , pp. 1-11
    • Manda, S.1    Sharma, S.2    Wani, A.3
  • 148
    • 84958246985 scopus 로고    scopus 로고
    • Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer’s disease mouse model
    • L. A. Mohamed, J. N. Keller, and A. Kaddoumi, “Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer’s disease mouse model,” Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, vol. 1862, no. 4, pp. 778–787, 2016.
    • (2016) Biochimica Et Biophysica Acta (BBA) – Molecular Basis of Disease , vol.1862 , Issue.4 , pp. 778-787
    • Mohamed, L.A.1    Keller, J.N.2    Kaddoumi, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.